Cannabis Sativa, Inc. (CBDS)
| Market Cap | 5.82M |
| Revenue (ttm) | 1.89M |
| Net Income (ttm) | -2.03M |
| Shares Out | 29.86M |
| EPS (ttm) | -0.09 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22,574 |
| Open | 0.230 |
| Previous Close | 0.240 |
| Day's Range | 0.000 - 0.000 |
| 52-Week Range | 0.140 - 1.820 |
| Beta | 1.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CBDS
Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through two segments, PrestoCorp and GKMP. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology; and operates as a contract manufacturer of products containing hemp-based cannabidiol (CBD). Its products under development include Re...
News
CBGA Found in Patented Strain Effective in Blocking Covid
MESQUITE, NV / ACCESSWIRE / January 17, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that the cannabis compound CBGA found in its patented strain patented strain Equadorian Sativa, or CTA (US PP ...